Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Durable Responses and Cystectomy Avoidance with IL-15 Receptor Agonist NAI plus BCG In BCG-Unresponsive NMIBC with Carcinoma In Situ +/- Papillary Disease.
Journal: The Journal of urology
Published: July 06, 2026
Prolonged Progression-Free Survival, Disease-Free Survival, and Cystectomy Avoidance With IL-15 Receptor Lymphocyte-Stimulating Agent NAI Plus Bacillus Calmette-Guérin in Bacillus Calmette-Guérin-Unresponsive Papillary-Only Nonmuscle-Invasive Bladder Cancer.
Journal: The Journal of urology
Published: September 16, 2025
Feasibility of Pay for Performance and Transparency Interventions on the Selection and Quality of Observational Management for Patients With Low-Risk Prostate Cancer in the Community Practice.
Journal: Urology practice
Published: October 25, 2024
IL-15 Superagonist NAI in BCG-Unresponsive Non-Muscle-Invasive Bladder Cancer.
Journal: NEJM evidence
Published: January 01, 2023
Validation of an mRNA-based Urine Test for the Detection of Bladder Cancer in Patients with Haematuria.
Journal: European urology oncology
Published: April 27, 2020
Prostatic Urethral Lift (PUL) for obstructive median lobes: 12 month results of the MedLift Study.
Journal: Prostate cancer and prostatic diseases
Published: October 13, 2018
A multi-institutional prospective trial in the USA confirms that the 4Kscore accurately identifies men with high-grade prostate cancer.
Journal: European urology
Published: July 30, 2014
Showing 1-12 of 12
Last Updated: 09/26/2026